** Shares of medical device maker Kestra Medical Technologies KMTS.O set to open 95% above offer price in Nasdaq debut
** Stock indicated to open at $33.15 vs $17 IPO price
** KMTS, backed by buyout firm Bain Capital, sold ~11.9 mln shares in its upsized offering - 19% more than initially offered, and above its marketed range of $14 and $16 apiece to raise $202 mln
** Listing marks first notable March IPO and the third medical device maker flotation in New York since October
** KMTS competes in the wearable cardioverter defibrillator market that has been dominated by Zoll Medical
** BofA Securities, Goldman Sachs and Piper Sandler were the lead bookrunners for the offering
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。